|
業務類別
|
Biotechnology |
|
業務概覽
|
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its tworare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD). |
| 公司地址
| One Cavendish Place, 4th Floor, London, GBR, W1G 0QF |
| 電話號碼
| +44 3330237300 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.mereobiopharma.com |
| 員工數量
| 39 |
| Mr. Charles Sermon |
General Counsel & Company Secretary |
-- |
09/04/2026 |
| Dr. Denise Vera Scots-Knight, PhD |
Executive Director,Chief Executive Officer |
英鎊 477.70K |
09/04/2026 |
|
|
| Mr. Michael Stephen Wyzga |
Non-Executive Director,Chairman |
09/04/2026 |
| Dr. Deepika Rachel Pakianathan |
Non-Executive Director |
09/04/2026 |
| Dr. Anders Olof Adolf Ekblom |
Non-Executive Director |
09/04/2026 |
| Dr. Annalisa Mary Jenkins, F.R.C.P.,M.B.B.S. |
Non-Executive Director |
09/04/2026 |
| Mr. Marc J. Yoskowitz |
Non-Executive Director |
09/04/2026 |
| Mr. Daniel Shames |
Non-Executive Director |
09/04/2026 |
| Mr. Pierre Jacquet |
Non-Executive Director |
09/04/2026 |
| Dr. Jeremy Bender, M.B.A.,PhD |
Non-Executive Director |
09/04/2026 |
| Mr. Justin Roberts |
Non-Executive Director |
09/04/2026 |
| Dr. Denise Vera Scots-Knight, PhD |
Executive Director,Chief Executive Officer |
09/04/2026 |
|
|
|
|
